---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-23-010813"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2023-04-04T23:59:59+00:00"
generated_at: "2026-06-17T06:25:47.986976+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.2
calibrated_materiality_score: 0.2
confidence: "high"
source: SEC EDGAR
---

# Director Jeffrey Segal resigns from INVO Bioscience board, no disagreement

## Summary
- Jeffrey Segal, MD resigned as director effective March 31, 2023.
- Resignation not due to any disagreements with the company regarding operations, policies, or practices.
- The company has not announced a replacement for the vacant board seat.

## SEC filing metadata
- accession: 0001493152-23-010813
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2023-04-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.2
- calibrated_materiality_score: 0.2
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315223010813/0001493152-23-010813-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315223010813/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-23-010813
- JSON: https://secwatch.observer/filing/0001493152-23-010813.json
- Plain text: https://secwatch.observer/filing/0001493152-23-010813.txt

## Key facts
- Executive change
  Jeffrey Segal resigned as director at INVO Fertility, Inc..
  - Action: resigned
  - Role: director
  source text: On March 31, 2023, Jeffrey Segal MD submitted his resignation as a director of INVO Bioscience, Inc. (the “Company”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315223010813/0001493152-23-010813-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.